Status:
RECRUITING
Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Breast Neoplasms
Radiation Pneumonia
Eligibility:
FEMALE
18+ years
Brief Summary
Prospective cohort research to study the state of oxygen metabolism, reserve capabilities of cardiovascular and respiratory systems in patients with breast cancer to create a program of prevention and...
Detailed Description
After a discussion about the possibility of participating in the study, the patient is presented with an informed consent form and all questions of interest are explained. If consent to participate in...
Eligibility Criteria
Inclusion
- established diagnosis of malignant breast neoplasm;
- signed informed voluntary consent of the patient to participate in the study.
Exclusion
- contraindications to the use of inhaled corticosteroids (presence of active or inactive pulmonary tuberculosis, fungal, viral or bacterial infection of the respiratory organs);
- lung diseases requiring baseline therapy with glucocorticosteroids (chronic obstructive pulmonary disease, bronchial asthma);
- mental and/or musculoskeletal impairments that make it impossible to adequately perform the exercise test, cooperate with the patient and interpret the results;
- conditions and diseases requiring emergency surgical intervention and/or observation and treatment in an ICU setting;
- patient's refusal to participate in this clinical trial at any stage of the study.
Key Trial Info
Start Date :
July 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 18 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06069115
Start Date
July 18 2023
End Date
July 18 2026
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meshalkin Scientific Research Center of the Ministry of Health of Russia
Novosibirsk, Novosibirsk Oblast, Russia, 630055